SCHEDULE Filed 2025-02-14 Event 2025-02-12 SEC 0001171843-25-000871 →

Nijhawan Pardeep → Edesa Biotech, Inc. EDSA

Stake: 19.99% Shares: 1,596,581 CUSIP: 27966L306 Class: Common Shares, no par value per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 15/100 · Filer 90d Win Rate: 100% · Hist. 90d Edge: +7.5%

Passive Schedule 13G filer baseline
High conviction ownership stake (20.0%)
Moderate short days-to-cover (3.5 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

11 13D/G filings on this issuer

10 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 3.51

161,309 shares short · -20.8% vs prior

Post-Filing Returns · since 2025-02-12 on EDSA

+1 day

+74.7%

+5 days

+34.4%

+30 days

+28.5%

+60 days

+28.0%

+90 days

+7.5%

+180 days

+13.4%

Anchor price 1.86 on closest trading day on/after 2025-02-12. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Edesa Biotech, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-26	SCHEDULE 13G	Stonepine Capital Management, LLC	—	—	view →
2026-08-25	SCHEDULE 13D/A	Nijhawan Pardeep	—	1,164,676	view →
2026-08-25	SCHEDULE 13D/A	Velan Capital Investment Management LP	—	1,081,385	view →
2026-06-18	SCHEDULE 13G	INTEGRATED CORE STRATEGIES (US) LLC	—	—	view →
2026-06-16	SCHEDULE 13D/A	Nijhawan Pardeep	—	1,164,676	view →
2020-01-23	SC	10379085 Canada Inc.	—	—	view →
2020-01-16	SC	Pardeep Nijhawan Medicine Professional Corp	—	—	view →
2020-01-16	SC	Lumira Capital Investment Management Inc.	—	—	view →
2019-09-10	SC	10379085 Canada Inc.	—	—	view →
2019-09-10	SC	Inveready Innvierte Biotech II, S.C.R. S.A	—	—	view →

Other Filings by Nijhawan Pardeep

Filed	Form	Issuer	Stake	Shares
2026-08-25	SCHEDULE 13D/A	EDESA BIOTECH, INC.	—	1,164,676	view →
2026-06-16	SCHEDULE 13D/A	EDESA BIOTECH, INC. EDSA	—	1,164,676	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →